| Bioactivity | EGFR-TK-IN-3 (3) is an EGFR TK inhibitor, with an IC50 of 2.33 μM against Erlotinib (HY-50896)-resistant A549 cells[1]. |
| Invitro | 该化合物的抗癌作用机制涉及EGFR TK抑制活性和肺癌细胞产生活性氧的能力的结合[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> EGFR-TK-IN-3 相关抗体: |
| Formula | C38H46FeN6O5 |
| Molar Mass | 722.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Przemysław Biegański, et al. Organometallic–Erlotinib Conjugates Active against Lung Cancer Cells and as Emerging Virus Entry Inhibitors. Organometallics 2024. |